Drug Approval | December 12, 2022
Zydus receives USFDA approval to market Silodosin and Pregabalin capsules
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
Topiramate Extended-Release capsule had annual sales of US $68.8 mn in the United States according to IQVIA data (IQVIA MAT Sep 2022)
Cyclophosphamide Capsules, 25 mg and 50 mg, have an estimated market size of US$ 8 million for twelve months ending Sep 2022 according to IQVIA.
Doxycycline Capsules (RLD Oracea) had estimated annual sales of US $215 million in the US
Mesalamine Extended-Release Capsules are indicated for the maintenance of remission of ulcerative colitis in adults.
According to IQVIA sales data for the 12-month period ending September 2022, the Gilenya Capsules, 0.5 mg market achieved annual sales of approximately US $1.8 billion
Valbenazine Capsules had annual sales of US $781 million in the United States according to IQVIA data
Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures
Amantadine Extended-Release capsules had annual sales of US $2.7 million in the United States according to IQVIA data
Lenalidomide is used to treat various types of cancers.
Subscribe To Our Newsletter & Stay Updated
